Lifevantage Corp (LFVN) stock
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 16/3023% below fair value
$4.97−0.07 (-1.39%)
Close on Nov 13, 2026Market cap $62.26MP/E 23.7Yield 3.72%
Lifevantage total assets
Total assets on the balance sheet at the end of each period.
Lifevantage's total assets was $59.21M at Sep 30, 2026. For fiscal 2026 it was $62.11M, down 13.7% from the year before. Over ten years it grew 2.0% a year on average. The highest annual figure on record is $78.73M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $62.11M | -13.7% |
| FY2025 | Jun 30, 2025 | $71.96M | +19.3% |
| FY2024 | Jun 30, 2024 | $60.30M | -8.8% |
| FY2023 | Jun 30, 2023 | $66.12M | -6.5% |
| FY2022 | Jun 30, 2022 | $70.71M | -10.2% |
| FY2021 | Jun 30, 2021 | $78.73M | +33.7% |
| FY2020 | Jun 30, 2020 | $58.88M | +6.5% |
| FY2019 | Jun 30, 2019 | $55.27M | +8.1% |
| FY2018 | Jun 30, 2018 | $51.14M | +13.0% |
| FY2017 | Jun 30, 2017 | $45.25M | -11.0% |
| FY2016 | Jun 30, 2016 | $50.86M | +27.8% |
| FY2015 | Jun 30, 2015 | $39.78M | -26.3% |
| FY2014 | Jun 30, 2014 | $54.00M | -2.7% |
| FY2013 | Jun 30, 2013 | $55.48M | +24.6% |
| FY2012 | Jun 30, 2012 | $44.53M | +256.3% |
| FY2011 | Jun 30, 2011 | $12.50M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $59.21M | -3.9% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $62.11M | -13.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $62.13M | -19.6% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $61.17M | -10.7% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $61.58M | +0.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $71.96M | +19.3% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $77.24M | +26.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $68.53M | +9.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $61.46M | -7.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $60.30M | -8.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $61.31M | -8.6% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $62.68M | -7.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $66.60M | -1.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $66.12M | -6.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $67.08M | -7.1% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $67.83M | -6.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $67.60M | -10.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $70.71M | -10.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $72.22M | -3.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $72.25M | -2.9% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $75.60M | +7.7% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $78.73M | +33.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $75.12M | +43.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $74.43M | +35.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $70.21M | +25.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $58.88M | +6.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $52.33M | -3.3% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $55.02M | +1.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $56.00M | +7.9% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $55.27M | +8.1% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $54.11M | +6.2% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $54.09M | +18.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $51.92M | +15.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $51.14M | +13.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $50.93M | +9.0% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $45.66M | -1.8% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $44.79M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $45.25M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $46.74M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $46.52M | – |
See a number that looks wrong?